BOYA
Lv32
260 积分
2022-04-03 加入
-
Eltrombopag reduces clinically relevant thrombocytopenic events in higher risk MDS and AML
23小时前
求助中
-
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trial
13天前
已完结
-
The new era of primary immune thrombocytopenia management in adults: A narrative review of current and emerging treatments
15天前
已完结
-
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
2个月前
已完结
-
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
-
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
3个月前
已完结
-
Utility of Thrombopoietin Receptor Agonists (TPO-RAs) for Prolonged Thrombocytopenia After CAR-T Cell Therapy
3个月前
已完结
-
Persistent thrombocytopenia in liver transplant patients
4个月前
已完结